TABLE 10.
BLVA 20/40 OR BETTER | BLVA WORSE THAN 20/40 | |||||
---|---|---|---|---|---|---|
| ||||||
Time post Tx |
RBZ+ PBI (%) |
PBI (%) |
P* |
RBZ+ PBI (%) |
PBI (%) |
P* |
12 months | 19/22 (86.4) | 44/53 (83.0) | .51 | 1/2 (50.0) | 3/18 (16.7) | .37 |
24 months | 20/22 (90.9) | 26/44 (59.1) | .007 | 1/2 (50.0) | 8/26 (30.8) | .55 |
Fisher’s exact test
BLVA: baseline visual acuity; Tx:treatment; RBZ: ranibizumab; PBI: proton beam irradiation